MediPharm Labs (TSE:LABS) Stock Price Down 7.7% – Should You Sell?

Shares of MediPharm Labs Corp. (TSE:LABS) were down 7.7% during mid-day trading on Monday . The company traded as low as C$0.06 and last traded at C$0.06. Approximately 161,838 shares were traded during mid-day trading, an increase of 0% from the average daily volume of 161,042 shares. The stock had previously closed at C$0.07.

MediPharm Labs Stock Performance

The company has a debt-to-equity ratio of 0.56, a quick ratio of 3.10 and a current ratio of 2.77. The company has a market capitalization of C$27.35 million, a PE ratio of -3.25 and a beta of -0.38. The stock has a fifty day moving average of C$0.07 and a 200 day moving average of C$0.07.

About MediPharm Labs

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.